Armin Ghobadi MD
Hematologic Oncology
Associate Professor of Medicine, Division of Medical Oncology Clinical Director, Center for Gene and Cellular Immunotherapy (CGCI) at Washington University School of Medicine in St. Louis
Join to View Full Profile
4921 Parkview Pl# DvSaint Louis, MO 63110
Phone+1 314-454-8304
Fax+1 314-454-5902
Dr. Ghobadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MD Anderson Cancer CenterBone Marrow Transplant and Cellular Therapy Fellowship, 2012 - 2013
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2006 - 2009
Iran University of Medical SciencesClass of 2001
Certifications & Licensure
MO State Medical License 2011 - 2026
TX State Medical License 2012 - 2015
Clinical Trials
- Mosunetuzumab Consolidation Therapy After autoSCT in r/r Aggressive B Cell Lymphoma Start of enrollment: 2022 Dec 22
Roles: Contact, Principal Investigator
- Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy Start of enrollment: 2022 Feb 28
Roles: Principal Investigator, Contact
- Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) After Failure of Rituximab or Rituximab and Chemotherapy Start of enrollment: 2017 Dec 29
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsBenefit of axicabtagene ciloleucel versus chemoimmunotherapy in older patients and/or patients with poor ECOG performance status with relapsed or refractory large B-ce...Matthew A Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L Locke, Tanya Siddiqi
American Journal of Hematology. 2024-05-01 - Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled...Dilan A Patel, Fei Wan, Kathryn Trinkaus, Daniel G Guy, Natasha Edwin
Clinical Lymphoma, Myeloma & Leukemia. 2023-07-01 - 135 citationsFive-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphoma.Sattva S Neelapu, Caron A Jacobson, Armin Ghobadi, David B Miklos, Lazaros J Lekakis
Blood. 2023-05-11
Books/Book Chapters
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
